Oncobesity News Posts

Pharmac seeking clinical advice on funding Wegovy weight loss medication
Pharmac received two applications to fund Wegovy or semaglutide – a GLP-1 receptor agonist for weight loss.

DR MARC SIEGEL: America, beware of false weight loss gods
Oprah Winfrey is on a book tour promoting her new book, “Enough: Your Weight and What It’s Like to Be Free.” In 2023, she reportedly

UK supermarkets go all out for ‘Jab-uary’ with food for those on weight-loss drugs
M&S, Morrisons and Ocado among retailers bringing out ranges targeting shoppers taking Wegovy or similar Veganuary and dry January are among the new year health

Oprah Winfrey Says She Had to Let Go of Shame Over GLP-1 Use

I compared Costco shopping carts of Kirkland Signature products and brand names. The price differences surprised me.
Major retailers typically have several in-house brands. Costco just has one: Kirkland Signature. Kevin Carter/Getty Images Costco sells a lot of brand-name goods at a

5 things doctors want you to know before you start taking a GLP-1
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still matter, doctors say.

What science says about how weight-loss drugs affect cancer risk
Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers.

Physician-Journalist Shines Light on Measles Upsurge and New GLP-1 Study
KFF Health News editor-at-large for public health Céline Gounder discussed an increase in measles cases in the U.S. on CBS News’ CBS Mornings on Jan.

Down 50%, are Greggs shares a top turnaround investment for 2026?
Greggs‘ (LSE: GRG) shares have tanked recently. Over the last 15 months, theyâve fallen about 50%. So could they be a top turnaround play for

3 arrested after allegedly robbing delivery driver of GLP-1 drugs at pharmacy
Three men are accused of driving from New York to rob a delivery driver who was dropping off GLP-1 medications to a Bucks County pharmacy

McKinsey Report: The Rise of Health Services Technology (HST) in a Decade of Strain
What You Should Know – A new McKinsey & Company report reveals that Health Services Technology (HST) has become the fastest-growing segment in U.S. healthcare,

Don’t Rely Too Much on Those ‘GLP-1 Friendly’ Labels
Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in US supermarkets as a growing number of Americans try obesity

The protein boom: Starbucks, Subway and beyond load up menus
A growing list of restaurants are packing their menus with protein as more Americans opt for healthier diets. Subway recently announced that it was kicking

Oprah has endured as a weight-loss icon. Not even GLP-1s can change that.
Oprah Winfrey has massively influenced wellness and diet culture for decades, now taking the spotlight to share her experience with GLP-1s. Don Arnold/Getty Images Oprah

Novo’s Wegovy Pill Looks A Lot Like Zepbound — In One Week – Investor’s Business Daily
Novo’s Wegovy Pill Looks A Lot Like Zepbound — In One Week Investor’s Business Daily Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’

Novo’s Wegovy pill tracks 3,071 prescriptions in first days of launch – Reuters
Novo’s Wegovy pill tracks 3,071 prescriptions in first days of launch Reuters Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch CNBC Lubbock Doctor

‘Bar Rescue’ host Jon Taffer on new restaurant reality: Smaller portions, lighter appetites and higher costs
America’s restaurant industry is quietly reworking its playbook as weight-loss drugs change how people eat, how much food they leave behind and what they are

Incretin Based Therapy in Heart Failure with Preserved Ejection Fraction
Join the American Heart Association for an insightful session with Dr. Clyde Yancy and Dr. Dhruv Kazi. Recent clinical trials demonstrate the efficacy of incretin-based

Arthur Brooks: Do GLP-1s Make Us Happy?
In my column last Monday, I wrote about how to make better New Year’s resolutions—ones that are less likely to flop, but that are also

Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading
More than 3,000 prescriptions were written for Novo’s GLP-1 pill in its first week on the market. Elsewhere, Emergent reached a settlement over a trading

‘Another self own’: Trump comment sparks internet rumors of president on Ozempic
President Donald Trump touted Friday his new health care plan, which he dubbed “The Great Health Care Plan” during a press conference from the White

‘Shamed’ Oprah Winfrey ‘Blamed Herself’ for Packing on the Pounds Before Using Weight Loss Medications to Shed 50Lbs — And Now She Can’t Quit the Jabs
Oprah dropped about 50 pounds after going on GLP-1 drugs two and a half years ago, but then quickly gained back 20 pounds when she

Signaling architecture of the glucagon-like peptide-1 receptor
The glucagon-like peptide-1 receptor (GLP-1R) is a class B1 G protein–coupled receptor and major therapeutic target in type 2 diabetes and obesity. Beyond its canonical

GLP-1 physiology and pharmacology along the gut-brain axis
Historically, antiobesity medications have been modestly effective at best, with side-effect profiles that limit compliance and often preclude the long-term therapy required to maintain weight

Food Exec Brief: Margin Preservation’s Urgent Mandate, AI’s Workforce Revolution, and Alternative Protein’s Commercial Breakthrough
Welcome to this week’s Food Exec Brief, your strategic intelligence roundup covering the industry’s desperate fight to preserve margins amid relentless cost pressures, AI and

Long-term GLP-1 use trims medical cost growth: Aon
Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from

Taco Bell rolls out new ‘luxe’ $3 value menu as fans debate the tradeoffs
A major fast-food chain is revamping its value menu as diners grow more price-conscious — and the early reaction is split. Taco Bell is expanding

Summary of JP Morgan Conference in Obesity and Metabolic Diseases
Here’s a summary of the major announcements and trends from the 44th Annual JP Morgan Healthcare Conference in San Francisco (January 12–15, 2026) specifically in

Day 1 @ JP Morgan in Obesity Drugs and Therapies
JP Morgan 2026: Obesity & GLP-1 Therapies Take Center StageWhat the Latest Deals and Data Mean for the Future of Metabolic MedicineThe J.P. Morgan Healthcare

Day 2 @ JP Morgan in Obesity Drugs and Therapies
Here are the **highlights from Day 2 of the JP Morgan Healthcare Conference (San Francisco) specifically related to obesity, weight-gain therapies, and related drug developments

Sunlight.com Survey: 4 in 10 Overweight Americans Say They’ll Try a GLP-1 Pill in 2026
Most current GLP-1 users are interested in switching to an oral form KIRKLAND, Wash., Jan. 16, 2026 /PRNewswire/ — A new survey from Sunlight.com finds

#JPM26: Sandoz CEO on Ozempic generic launch plans for 2026
SAN FRANCISCO — Throughout his 53 meetings at this year’s JPMorgan Healthcare Conference, Richard Saynor mulled a charitable idea about the topic on everyone’s minds.

Resmed highlights AI-driven CPAP tech, competitive bidding win and GLP-1 insights at J.P. Morgan Hea – HME News
Resmed highlights AI-driven CPAP tech, competitive bidding win and GLP-1 insights at J.P. Morgan Hea HME News

Signal Boost 2026
Signal Boost 2026 Second week of January. Year of the Horse. Back in the saddle. As I point my GPS toward a familiar constellation of

What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage?
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns

Fermentation, Vol. 12, Pages 53: High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli
Fermentation, Vol. 12, Pages 53: High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli Fermentation doi: 10.3390/fermentation12010053 Authors:

The Biological Cost of Ozempic and Other GLP-1s
Get the Highest Quality Electrolyte https://euvexia.com . Losing belly fat is hard so you may wonder if a GLP-1 will work. The question isn’t whether

David Protein CEO Peter Rahal on the rise of protein bars, impact of GLP-1s and protein intake
Peter Rahal, David Protein CEO, joins ‘Squawk Box’ to discuss the rise and advancements of protein bars, the supplementation of creatine, impact of GLP-1 weight

Glucagon-like peptide-1 medicines and cancer
Nature Cancer, Published online: 16 January 2026; doi:10.1038/s43018-025-01110-1 Yabut and Drucker discuss clinical and preclinical evidence about the potential roles of GLP-1 medicines on cancer

Weight-loss drugs may trigger the next restaurant crisis
Chad Finkelstein is a partner at the law firm of Dale & Lessmann LLP and chair of the firm’s franchising, licensing and distribution group. His